Ralimetinib
目录号: A21942
p38 MAPK α/β 抑制剂
Ralimetinib(LY2228820)是一种强效且选择性的,与ATP竞争的p38 MAPK α/β抑制剂,其IC50分别为5.3和3.2 nM。
| Discription | Ralimetinib (LY2228820) is a potent and selective, ATP-competitive inhibitor of p38 MAPK α/β, with IC50s of 5.3 and 3.2 nM, respectively. | ||
|---|---|---|---|
| Targets |
|
| 目录号 | A21942 |
|---|---|
| 分子式 | C24H29FN6 |
| 分子量 | 420.53 |
| CAS号 | 862505-00-8 |
| SMILES | NC1=NC2=CC=C(C3=C(C4=CC=C(F)C=C4)N=C(C(C)(C)C)N3)N=C2N1CC(C)(C)C |
| 其他名称 | LY2228820, LY 2228820, LY-2228820 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro (25°C) | DMSO | Warmed: 30 mg/mL (48.9 mM) | |
| Water | Warmed: 85 mg/mL (138.72 mM) | ||
| Ethanol | 3 mg/mL (4.89 mM) | ||
| In vivo | Saline | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.78 mL | 118.9 mL | 237.8 mL |
| 0.5 mM | 4.76 mL | 23.78 mL | 47.56 mL |
| 1 mM | 2.38 mL | 11.89 mL | 23.78 mL |
| 5 mM | 0.48 mL | 2.38 mL | 4.76 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2